Neural stem cells grown from one of the federally approved human embryonic stem cell lines proved to be inferior to neural stem cells derived from fetal tissue donated for research, a UCLA study has found.
Researchers from the Institute for Stem Cell Biology and Medicine at UCLA coaxed cells from the federally approved line to differentiate into neural stem cells, a process that might one day be used to grow replacement cells to treat such debilitating diseases as Parkinson's and Alzheimer's. However, the neural stem cells expressed a lower level of a metabolic gene called CPT 1A, a condition that causes hypoglycemia in humans.
The study may shed new light on better ways to grow neural and other stem cells in the lab so they mirror normal cells and promote normal functioning, said Guoping Fan, an assistant professor of human genetics and a researcher in UCLA's stem cell institute. The study appears this week in an early online edition of the journal Human Molecular Genetics.
"This study is a very important first step in looking at the differentiation process in neural stem cells," said Fan, senior author of the study. "Now we have a direct measurement of the types of cells that eventually, we hope, will be used for transplantation. We can tell, are they normal or not. Understanding why these cells under-expressed CPT 1A is the first step in a comprehensive understanding of cells obtained from human embryonic stem cells."
The study, Fan said, deals with one of the most important aspects in stem cell biology - potential abnormalities in cells derived from human embryonic stem cells. Stem cells with abnormalities may not effectively treat the diseases they were created to treat, or they may result in secondary problems such as hypoglycemia, Fan said.
UCLA researchers also compared the neural stem cells they grew to cancer cells to ensure that the neural stem cells did not have any abnormalities in a DNA modification associated with gene silencing. The abnormal DNA modification is characteristically a hallmark of cancer cells. The good news, Fan said, is that the neural stem cells in their study did not share any abnormal characteristics associated with cancer. The means, theoretically, that a patient undergoing transplantation with these neural stem cells would not later develop a malignancy.
In the three-year study, researchers compared the neural stem cells grown in the lab from human embryonic stem cells to neural stem cells that already had differentiated and were derived from donated fetal tissue. The question: would the cell lines be the same and mirror the normal neural stem cells found in humans or would one cell line be superior to the other?
"Compared to the normal cells derived from the fetal tissue, the level of gene expression in the neural stem cells grown in the lab is lower," Fan said. "Proper levels of gene expression are essential for normal cell function. This study suggests that the differentiation procedure used in the lab needs to be improved so all genes are properly regulated in the stem cells we grow."
Fan and his colleagues now are studying what may have gone awry in the process they used to coax the human embryonic stem cells to differentiate into neural stem cells that may have resulted in the under-expression of the CPT 1A gene. They're also planning to repeat their work on other federally approved stem cell lines to see if the abnormality was an aberration found only in this one stem cell line. Fan and other UCLA researchers said the abnormality found in the federally approved stem cell line reinforces the need for other embryonic stem cells lines on which to conduct research.
To compare the neural stem cells, researchers extracted DNA fragments and used high throughput micro array technology to study the pattern of DNA cytosine methylation. They also monitored for levels of gene expression that are necessary for cell function as well as abnormalities that might be problematic.
"Any stem cells that might one day be used for transplantation have to be as close as possible to normal stem cells," Fan said. "The next step is to see if we can improve the way we grown these cells. I think we learned an important lesson with this study."
Kim Irwin | EurekAlert!
New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences
The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
21.11.2017 | Physics and Astronomy
21.11.2017 | Physics and Astronomy
21.11.2017 | Life Sciences